News | March 04, 2014

Controversial Mammogram Study to Be Tackled at Miami Breast Cancer Conference

March 4, 2014 — Physicians’ Education Resource (PER) announced that “The Great Mammography Debate” has been added to the 31st annual Miami Breast Cancer Conference agenda, in light of a controversial study that suggests mammograms do not reduce the number of women who die from breast cancer. Registration is open for the conference, which will be hosted at the Fontainebleau Miami Beach, March 6-9.

The Canadian National Breast Screening Study, released Feb. 11, has come under widespread fire for claiming “annual mammography in women aged 40 to 59 does not reduce mortality from breast cancer beyond that of physical examination or usual care when adjuvant therapy for breast cancer is freely available.”

Patrick Borgen, M.D., chairman of the Miami Breast Cancer Conference and chairman of surgery at Maimonides Medical Center in New York, is calling into question the validity of the research and has now added the debate to the conference’s agenda.

“This information has women across America scratching their heads,” said Borgen. “What we know is that this study is outrageous and probably the single most flawed trial in the history of mammography trials.”

Given the controversy of the study’s findings, physicians everywhere are facing new concerns from patients who are questioning the need for mammograms. As such, Borgen and other members of the Miami Breast Cancer Conference’s faculty aim to tackle that issue.

“I believe this report may give some women a reason to not get a mammogram, so physicians are going to face questions,” said Borgen. “At the Miami Breast Cancer Conference, we are going to discuss how to explain to patients why mammograms are still important, among many other topics.”

The two main themes at this year’s Miami Breast Cancer Conference are (1) personalizing care — matching the treatment to the patient, and (2) quality of life both for the patient and the doctor.

For more information: www.gotoper.com

Related Content

Clinical Trial Testing Topical Gel to Reduce Breast Density
News | Breast Density | June 19, 2018
Women with dense breast tissue soon might be adding a new product to their skincare routine to help them fight breast...
California Women In Favor of Extending State's Breast Density Inform Law
News | Breast Density | June 15, 2018
A recent survey of California women found that 95 percent of respondents want the state’s breast density inform law to...
Women More Likely to Use Other Preventive Health Services Following Mammography
News | Mammography | June 13, 2018
Medicare beneficiaries who undergo breast cancer screening with mammography are more likely than unscreened women to...
How AI and Deep Learning Will Enable Cancer Diagnosis Via Ultrasound

The red outline shows the manually segmented boundary of a carcinoma, while the deep learning-predicted boundaries are shown in blue, green and cyan. Copyright 2018 Kumar et al. under Creative Commons Attribution License.

News | Ultrasound Imaging | June 12, 2018 | Tony Kontzer
June 12, 2018 — Viksit Kumar didn’t know his mother had...
Breast imaging technologies have seen a rapid evolution.

Breast imaging technologies have seen a rapid evolution.

Feature | Women's Health | June 05, 2018 | By Jeff Zagoudis
Breast imaging technologies have evolved rapidly in the last two decades to help physicians detect breast cancers at
Breast Cancer Survivors Not Getting Recommended Number of Mammograms Post-Surgery
News | Mammography | May 24, 2018
Breast cancer survivors are not getting the recommended level of screening post-surgery, according to a newly-published...
Breast Cancer Places Greater Financial Burden on Black Women
News | Women's Health | May 16, 2018
Having breast cancer placed a significantly greater financial strain on black women than white women, according to a...
FDA's MQSA Accreditation Bodies Approved for Tomosynthesis Accreditation

Image courtesy of Fujifilm.

Feature | Mammography | May 14, 2018
On April 9, 2018, the U.S. Food and Drug Administration (FDA) announced that all four of its Mammography Quality...
Overlay Init